A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

NCT06537752 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1052

Last updated 2025-09-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate ethanol-induced symptoms and safety in breast cancer patients with neoadjuvant/adjuvant chemotherapy including Non-ethanol formulation docetaxel before and after surgery

Conditions

Sponsors & Collaborators

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06537752 on ClinicalTrials.gov